Upstream Processing

Articles

Lonza is expanding its microbial development capabilities at its Visp, Switzerland, site to support clinical and commercial drug development programs.

Lonza Invests in Microbial Development Lab Expansion

Fujifilm is expanding its R&D footprint at its California facility. 

Fujifilm Irvine Scientific Expands Cell Culture R&D Center

Feliza Mirasol is the science editor for 

The adoption of perfusion cell culture continues to advance with the help of PAT tools.

Perfusion Cell Culture is Gaining Ground Upstream

Advancements in bioprocessing technologies test microbial fermentation adaptability.

Bioprocessing Innovations Pose New Challenges for Fermentation

Corning’s new Ascent fixed bed reactor (FBR) system is an automated bioproduction platform designed to significantly improve yields and reduce bioproduction costs.

Corning’s New Cell and Gene Therapy Platform Demonstrates Large-Scale Bioproduction

Automation is one asset that benefits cell harvesting by cutting out laborious manual steps and minimizing contamination.

Cell Harvesting Sees Benefits from Automated Processes

The companies work to develop and supply advanced cell models that better reflect an in-vivo environment to improve drug discovery accuracy and efficiency.

Lonza to Supply Prequalified Hepatocytes for Use on CN Bio’s Organ-on-a-Chip Range

Cell-free expression is promising in preclinical applications, but still presents challenges to scale up for commercial production.

Cell-free Expression Systems Pose Cell Culture Alternative

Originally established in the 1970s as a fetal bovine serum supplier, Fujifilm Irvine Scientific continuously proved its strength in the cell culture solutions space.

Fujifilm Irvine Scientific Celebrates 50 Years of Providing Cell Culture Media Products and Services

Demand for recombinant microorganism-based cell culture supplements is rising on the back of lower contamination risk.

Manufacturing, Cell Culture and Fermentation